Brain Training for Substance Use Disorders

Part of paid clinical trials in Minneapolis, Minnesota.

Sponsor
Neurotype Inc.
Study ID
NCT06870110
Status
Recruiting
Apply to this trial

Conditions

  • Opioid Use Disorder

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Accepted

Interventions

  • Bias Modification Biofeedback — DEVICE
    The device uses EEG-based bias modification biofeedback intended to reduce attention to drug-related cues and increase attention to non-drug pleasant scenes. Specifically, the device measures perceptual biases from Event-Related Potential biomarkers related to Substance Use Disorders.

Study Details

Participants play games designed to train visual attention towards natural, non-drug-related scenarios. A biofeedback loop between gameplay and an electroencephalogram (EEG) system monitors game performance and guides game difficulty.

Key Dates

Start date
Jan 17, 2025
Status verified
Mar 2025
Primary completion
Aug 31, 2025
Completion
Aug 31, 2025

Study Design

Enrollment
40 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Biofeedback

Primary Outcome Measure

Change in ERP-Based Classification of Opioid-Related Attention Bias (Probability Score) [ Time Frame: Pre- to post-biofeedback session (same day, approximately 30 minutes) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Minnesota - Department of Psychiatry & Behavioral HealthMinneapolisMinnesota55454
Scott Burwell, PhD
[email protected]
612-790-9304
Justin Anker, PhD
[email protected]
612-273-9819
Justin Anker, PhD (PRINCIPAL_INVESTIGATOR)
Scott Burwell, PhD (SUB_INVESTIGATOR)

Find similar trials in Minneapolis, MN

By research site
University of Minnesota - Department of Psychiatry & Behavioral Health· Minneapolis, MN

Related Studies